Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Pharming Receives Agreement On Paediatric Investigation Plan For Rhucin(R) From The EMEA Paediatric Committee
Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that the Paediatric Committee (PDCO) of the European Medicines Agency (EMEA) has adopted an opinion agreeing the paediatric investigation plan (PIP) for Rhucin® (recombinant human C1 inhibitor) in the therapeutic area of immunology-rheumatology transplantation.

Discovery Of New Proteins May Lead To More Effective Treatment Of Endocarditis And Infections Associated With Implants
A research team at the Faculty of Odontology at Malmo University in Sweden has discovered two new proteins that are of importance to the survival of bacteria and their colonization of the human body. Besides enhancing our knowledge of the ability of bacteria to spread, the findings may also lead to more effective treatment of endocarditis and infections associated with implants.
News of the day
Slight Majority Of U.S. Residents Call Themselves 'Pro-life;' 76% Say Abortion Should Be Legal, Poll Shows
Seventy-six percent of U.S. residents believe that abortion should be legal, a finding in keeping with public opinion over the past three decades, according to a Gallup poll released on Saturday, the AP/Boston Globe reports (AP/Boston Globe, 5/16). However, 51% of respondents identified themselves as "pro-life," while 42% said they are "pro-choice" (Gallup poll, 5/16). The finding marks the first time since Gallup began asking about abortion rights in 1995 that a majority of respondents said they consider themselves "pro-life" (Nadeau, Boston Herald, 5/16). Last year"s poll showed that 50% of respondents consider themselves "pro-choice," compared with 44% who said they are "pro-life" (Abcarian, Los Angeles Times, 5/16).The new poll found that 53% of respondents believe abortion should be legal under some circumstances, 23% believe it should be legal under any circumstances and 22% believe it should be illegal under any circumstances (Boston Herald, 5/16). The percentage of respondents who oppose abortion rights in all cases rose slightly from last year, while those who support abortion rights in all cases decreased slightly. The Los Angeles Times reports that the percentage of respondents who oppose abortion rights in all circumstances and those who support abortion rights in all circumstances is "a virtual tie." The results have a margin of sampling error of plus or minus three percentage points.Respondents who labeled themselves as moderates and Republicans accounted for most of the change in views compared with past polls, as Democrats" views remained consistent with previous years, according to the Los Angeles Times. Gallup in its analysis wrote that it is "possible" that President Obama "has pushed the public"s understanding of what it means to be "pro-choice" slightly to the left, politically" (Los Angeles Times, 5/16). The survey was conducted between May 7 and May 10 (AP/Boston Globe, 5/16).Nancy Keenan, president of NARAL Pro-Choice America, said, "I am pretty confident that Americans really don"t want Roe v. Wade overturned." She added that the increase in respondents identifying as "pro-life" does not "square with what has happened in the last several elections," noting that voters have rejected several antiabortion-rights ballot measures in South Dakota, California, Oregon and Colorado since 2005. However, Charmaine Yoest, president of Americans United for Life, said, "It tracks pretty much with what we"ve always known: People generally are pro-life depending on how you ask the question" (Los Angeles Times, 5/16).
Medical Devices

GE, Big Vendors Corner EMR Market; Smaller Vendors Explore Health 2.0

Staying ahead of the upcoming drive to sell electronic health records to hospitals and physicians may be difficult for smaller vendors, Pharmawire/Financial Times reports. General Electric announced a program last week to provide health care organizations with financing options to purchase health technology through its financial services arm even as it sells electronic records through its health care wing. Other large vendors like Cerner and McKesson will be able to keep up, but smaller producers will be left behind, industry experts said. A rush of new customers is expected in upcoming years because the American Recovery and Reinvestment Act provides incentives - more than $20 billion - for health providers to purchase the technology (Avallone and Longpre, 6/24). In other news, Atlas Venture, a venture capital firm, is gearing up to make investments that will "improve health care by empowering patients," the Wall Street Journal"s blog, Venture Capital Dispatch, reports. The company has recently invested in Keas, a health 2.0 company that develops Web technologies that help consumers "better their health." Atlas partner and technology specialist Jeff Fagnan said "the firm may make four or five of these types of investments with its current fund... which closed at $283 million last year" (Gormley, 6/25). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009